Global Anticoagulants Market Study 2015-2025, by Segment (Platelet aggregation inhibitors (PAI), Low-molecular-weight Heparin (LMWH), Direct thrombin inhibitor (DTI)), by Market (VTE, ACS/MILow-molecular-weight Heparin (LMWH), AF), by Company (Bayer, Sanofi, Boehringer Ingelheim)

September 2018 | 86 pages | ID: G3C9A407975EN
99Strategy

Abstracts

Snapshot

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

The global Anticoagulants market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Platelet aggregation inhibitors (PAI)
• Low-molecular-weight Heparin (LMWH)
• Direct thrombin inhibitor (DTI)
• Direct factor Xa inhibitors (DFXa)
• Vitamin K antagonists (VKA)
• Others

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• VTE
• ACS/MI
• AF
• Others

Company Coverage (Sales data, Main Products & Services etc.):

• Bayer
• Sanofi
• Boehringer Ingelheim
• Johnson & Johnson
• Genentech (Roche)
• AstraZeneca
• Bristol-Myers Squibb
• Aspen
• Lilly
• Otsuka
• Pfizer
• Daiichi Sankyo
• The Medicines Company

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 Anticoagulants Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 ANTICOAGULANTS MARKET BY TYPE

2.1 By Type
  2.1.1 Platelet aggregation inhibitors (PAI)
  2.1.2 Low-molecular-weight Heparin (LMWH)
  2.1.3 Direct thrombin inhibitor (DTI)
  2.1.4 Direct factor Xa inhibitors (DFXa)
  2.1.5 Vitamin K antagonists (VKA)
  2.1.6 Others
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 VTE
  3.1.2 ACS/MI
  3.1.3 AF
  3.1.4 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 Bayer (Company Profile, Sales Data etc.)
5.2 Sanofi (Company Profile, Sales Data etc.)
5.3 Boehringer Ingelheim (Company Profile, Sales Data etc.)
5.4 Johnson & Johnson (Company Profile, Sales Data etc.)
5.5 Genentech (Roche) (Company Profile, Sales Data etc.)
5.6 AstraZeneca (Company Profile, Sales Data etc.)
5.7 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
5.8 Aspen (Company Profile, Sales Data etc.)
5.9 Lilly (Company Profile, Sales Data etc.)
5.10 Otsuka (Company Profile, Sales Data etc.)
5.11 Pfizer (Company Profile, Sales Data etc.)
5.12 Daiichi Sankyo (Company Profile, Sales Data etc.)
5.13 The Medicines Company (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Anticoagulants Market 2015-2018, by Type, in USD Million
Table Global Anticoagulants Market 2015-2018, by Type, in Volume
Table Global Anticoagulants Market Forecast 2019-2025, by Type, in USD Million
Table Global Anticoagulants Market Forecast 2019-2025, by Type, in Volume
Table Bayer Overview List
Table Anticoagulants Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Anticoagulants Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Anticoagulants Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Anticoagulants Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genentech (Roche) Overview List
Table Anticoagulants Business Operation of Genentech (Roche) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Anticoagulants Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Anticoagulants Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aspen Overview List
Table Anticoagulants Business Operation of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lilly Overview List
Table Anticoagulants Business Operation of Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Otsuka Overview List
Table Anticoagulants Business Operation of Otsuka (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Anticoagulants Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Anticoagulants Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table The Medicines Company Overview List
Table Anticoagulants Business Operation of The Medicines Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global Anticoagulants Market Growth 2015-2018, by Type, in USD Million
Figure Global Anticoagulants Market Growth 2015-2018, by Type, in Volume